{
  "actions": [
    {
      "acted_at": "2023-02-16",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2023-02-16",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s476-118",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "B001243",
      "district": null,
      "name": "Blackburn, Marsha",
      "original_cosponsor": true,
      "sponsored_at": "2023-02-16",
      "state": "TN",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B001305",
      "district": null,
      "name": "Budd, Ted",
      "original_cosponsor": false,
      "sponsored_at": "2023-11-14",
      "state": "NC",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000618",
      "district": null,
      "name": "Daines, Steve",
      "original_cosponsor": false,
      "sponsored_at": "2024-06-17",
      "state": "MT",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-02-16",
  "number": "476",
  "official_title": "A bill to amend title XI of the Social Security Act to protect access to genetically targeted technologies.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr5547-118",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Maintaining Investments in New Innovation Act",
  "sponsor": {
    "bioguide_id": "M000639",
    "district": null,
    "name": "Menendez, Robert",
    "state": "NJ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-02-16",
  "subjects": [
    "Genetics",
    "Health",
    "Medicare",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2023-02-16",
    "date": "2023-06-02T15:03:33Z",
    "text": "Maintaining Investments in New Innovation Act\n\nThis bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)"
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Maintaining Investments in New Innovation Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend title XI of the Social Security Act to protect access to genetically targeted technologies.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Maintaining Investments in New Innovation Act",
      "type": "short"
    }
  ],
  "updated_at": "2025-10-07T17:46:40Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/s/BILLSTATUS-118s476.xml"
}